Brigandi, Richard A.

GlaxoSmithKline (United States)

1 paper on CoChatORCID 0000-0003-1480-2429

Most cited papers

Verified
The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma
Spencer, A., Yoon, S.-S., Harrison, S. J., Morris, S. R., Smith, D. A., Brigandi, R. A., Gauvin, J., Kumar, R., Opalinska, J. B., & Chen, C. (2014) · Blood
Multiple Myeloma Research and TreatmentsPI3K/AKT/mTOR signaling in cancer
Cited by 142

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free